Histone Hyperacetylation during SV40 Transcription Is Regulated by p300 and RNA Polymerase II Translocation

Journal of Molecular Biology

Volumn 371, Issue 4, 2007, Pages 1022-1037

  Balakrishnan, Lata ^a   Milavetz, Barry ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

chromatin; histone hyperacetylation; RNA polymerase II; SV40; transcription

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ALPHA AMANITIN; HISTONE H3; HISTONE H4; PROTEIN P300; RNA POLYMERASE II;

ACETYLATION; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIMIAN VIRUS 40; VIRAL GENE DELIVERY SYSTEM;

SIMIAN VIRUS 40;

EID: 34547130607     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.06.080     Document Type: Article

References (62)

1. Fischle W., Wang Y., and Allis C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15 (2003) 172-183
2. Lachner M., and Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14 (2002) 286-298
3. Brownell J.E., and Allis C.D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6 (1996) 176-184
4. Balakrishnan L., and Milavetz B. Histone hyperacetylation in the coding region of chromatin undergoing transcription in SV40 minichromosomes is a dynamic process regulated directly by the presence of RNA polymerase II. J. Mol. Biol. 365 (2007) 18-30
5. Hensold J.O., Barth D., and Stratton C.A. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes. J. Cell Physiol. 168 (1996) 105-113
6. Lindell T.J., Weinberg F., Morris P.W., Roeder R.G., and Rutter W.J. Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science 170 (1970) 447-449
7. Kedinger C., Gniazdowski M., Mandel Jr. J.L., Gissinger F., and Chambon P. Alpha-amanitin: a specific inhibitor of one of two DNA-pendent RNA polymerase activities from calf thymus. Biochem. Biophys. Res. Commun. 38 (1970) 165-171
8. Rudd M.D., and Luse D.S. Amanitin greatly reduces the rate of transcription by RNA olymerase II ternary complexes but fails to inhibit some transcript cleavage modes. J. Biol. Chem. 271 (1996) 21549-21558
9. Chafin D.R., Guo H., and Price D.H. Action of alpha-amanitin during pyrophosphorolysis and elongation by RNA polymerase II. J. Biol. Chem. 270 (1995) 19114-19119
10. Kobor M.S., and Greenblatt J. Regulation of transcription elongation by phosphorylation. Biochim. Biophys. Acta 1577 (2002) 261-275
11. Dahmus M.E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271 (1996) 19009-19012
12. Riedl T., and Egly J.M. Phosphorylation in transcription: the CTD and more. Gene Expr. 9 (2000) 3-13
13. Oelgeschlager T. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J. Cell Physiol. 190 (2002) 160-169
14. Trigon S., Serizawa H., Conaway J.W., Conaway R.C., Jackson S.P., and Morange M. Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J. Biol. Chem. 273 (1998) 6769-6775
15. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20 (2000) 2629-2634
16. Garriga J.G.X. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 337 (2004) 15-23
17. Medlin J.E., Uguen P., Taylor A., Bentley D.L., and Murphy S. The C-terminal domain of pol II and a DRB-sensitive kinase are required for 3′ processing of U2 snRNA. EMBO J. 22 (2003) 925-934
18. Balakrishnan L., and Milavetz B. Reorganization of RNA polymerase II on the SV40 genome occurs coordinately with the early to late transcriptional switch. Virology 345 (2006) 31-43
19. Balakrishnan L., and Milavetz B. Programmed remodeling of hyperacetylated histone H4 and H3 organization on the SV40 genome during lytic infection. Virology 334 (2005) 111-123
20. Milavetz B. Hyperacetylation and differential deacetylation of histones H4 and H3 define two distinct classes of acetylated SV40 chromosomes early in infection. Virology 319 (2004) 324-336
21. Eadara J.K., and Lutter L.C. RNA polymerase locations in the simian virus 40 transcription complex. J. Biol. Chem. 268 (1993) 22020-22027
22. Ip Y.T., Jackson V., Meier J., and Chalkley R. The separation of transcriptionally engaged genes. J. Biol. Chem. 263 (1988) 14044-14052
23. Clayton A.L., Hazzalin C.A., and Mahadevan L.C. Enhanced histone acetylation and transcription: a dynamic perspective. Mol. Cell 23 (2006) 289-296
24. Mellor J. Dynamic nucleosomes and gene transcription. Trends Genet. 22 (2006) 320-329
25. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763
26. Reid G., Hubner M.R., Metivier R., Brand H., Denger S., Manu D., et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11 (2003) 695-707
27. Ryser S., Fujita T., Tortola S., Piuz I., and Schlegel W. The rate of c-fos transcription in vivo is continously regulated at the level of elongation by dynamic stimulus-coupled recruitment of P-TEFb. J. Biol. Chem. 282 (2007) 5075-5084
28. Mason P.B., and Struhl K. Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo. Mol. Cell 17 (2005) 831-840
29. Carrozza M.J., Li B., Florens L., Suganuma T., Swanson S.K., Lee K.K., et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123 (2005) 581-592
30. Yang X.J., and Gregoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 25 (2005) 2873-2884
31. Metivier R.P.G., Carmouche R.P., Hubner M.R., Reid G., Denger S., Manu D., et al. Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. EMBO J. 23 (2004) 3653-3666
32. Chuang H.C., Chang C.W., Chang G.D., Yao T.P., and Chen H. Histone deacetylase 3 binds to and regulates the GCMa transcription factor. Nucl. Acids Res. 34 (2006) 1459-1469
33. Ego T., Ariumi Y., and Shimotohno K. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. Oncogene 21 (2002) 7241-7246
34. Atsumi A.T.A., Kiyoi H., and Naoe T. Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivo. Biochem. Biophys. Res. Commun. 345 (2006) 1471-1480
35. Batsche E.Y.M., and Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nature Struct. Mol. Biol. 13 (2006) 22-29
36. Shilatifard A. Transcriptional elongation control by RNA polymerase II: a new frontier. Biochim. Biophys. Acta 1677 (2004) 79-86
37. Neish A.S., Anderson S.F., Schlegel B.P., Wei W., and Parvin J.D. Factors associated with the mammalian RNA polymerase II holoenzyme. Nucl. Acids Res. 26 (1998) 847-853
38. Wilson C.J., Chao D.M., Imbalzano A.N., Schnitzler G.R., Kingston R.E., and Young R.A. RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. Cell 84 (1996) 235-244
39. Cho R.J., Campbell M.J., Winzeler E.A., Steinmetz L., Conway A., Wodicka L., et al. A genome-wide transcriptional analysis of the mitotic cell cycle. Mol. Cell 2 (1998) 65-73
40. Joshi A.A., and Struhl K. Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation. Mol. Cell 20 (2005) 971-978
41. Keogh M.C., Kurdistani S.K., Morris S.A., Ahn S.H., Podolny V., Collins S.R., et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123 (2005) 593-605
42. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
43. Kundu T.K., Palhan V.B., Wang Z., An W., Cole P.A., and Roeder R.G. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell 6 (2000) 551-561
44. Kashanchi F., and Brady J.N. Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 24 (2005) 5938-5951
45. Nandiwada S.L., Li W., Zhang R., and Mueller D.L. p300/Cyclic AMP-responsive element binding-binding protein mediates transcriptional coactivation by the CD28 T cell costimulatory receptor. J. Immunol. 177 (2006) 401-413
46. Warner D.R., Pisano M.M., and Greene R.M. Functional analysis of CBP/p300 in embryonic orofacial mesenchymal cells. J. Cell Biochem. 99 (2006) 1374-1379
47. Black J.C., Choi J.E., Lombardo S.R., and Carey M. A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol. Cell 23 (2006) 809-818
48. Lu H., Pise-Masison C.A., Fletcher T.M., Schiltz R.L., Nagaich A.K., Radonovich M., et al. Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template. Mol. Cell. Biol. 22 (2002) 4450-4462
49. Guermah M., Palhan V.B., Tackett A.J., Chait B.T., and Roeder R.G. Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates. Cell 125 (2006) 275-286
50. Inukai N., Yamaguchi Y., Kuraoka I., Yamada T., Kamijo S., Kato J., et al. A novel hydrogen peroxide-induced phosphorylation and ubiquitination pathway leading to RNA polymerase II proteolysis. J. Biol. Chem. 279 (2004) 8190-8195
51. Nguyen V.T., Giannoni F., Dubois M.F., Seo S.J., Vigneron M., Kedinger C., and Bensaude O. In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucl. Acids Res. 24 (1996) 2924-2929
52. Kouskouti A., and Talianidis I. Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J. 24 (2005) 347-357
53. Khobta A., Ferri F., Lotito L., Montecucco A., Rossi R., and Capranico G. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells. J. Mol. Biol. 357 (2006) 127-138
54. Dubois M.F., Nguyen V.T., Bellier S., and Bensaude O. Inhibitors of transcription such as 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J. Biol. Chem. 269 (1994) 13331-13336
55. Stevens A.M.M. 5,6-Dichloro-1-beta-d-ribofuranosylbenzimidazole inhibits a HeLa protein kinase that phosphorylates an RNA polymerase II-derived peptide. Biochem. Biophys. Res. Commun. 159 (1989) 508-515
56. Payne J.M., and Dahmus M.E. Partial purification and characterization of two distinct protein kinases that differentially phosphorylate the carboxyl-terminal domain of RNA polymerase subunit IIa. J. Biol. Chem. 268 (1993) 80-87
57. Kube D., and Milavetz B. Generation of a nucleosome-free promoter region in SV40 does not require T-antigen binding to site I. Virology 172 (1989) 100-105
58. Hermansen R., Sierra M.A., Johnson J., Friez M., and Milavetz B. Identification of Simian virus 40 promoter DNA sequences capable of conferring restriction endonuclease hypersensitivity. J. Virol. 70 (1996) 3416-3422
59. Friez M., Hermansen R., and Milavetz B. Chromatin structure of the simian virus 40 late promoter: a deletional analysis. J. Virol. 73 (1999) 1990-1997
60. IJpenberg A., Tan N.S., Gelman L., Kersten S., Seydoux J., Xu J., et al. In vivo activation of PPAR target genes by RXR homodimers. EMBO J. 23 (2004) 2083-2091
61. Sandalon Z.O.A. Self-assembly and protein-protein interactions between the SV40 capsid proteins produced in insect cells. Virology 237 (1997) 414-421
62. Milavetz B.I. SP1 and AP-1 elements direct chromatin remodeling in SV40 chromosomes during the first 6 hours of infection. Virology 294 (2002) 170-179